LifeScience Emerging Biotech
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity...
July 07, 2023 | News
EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...
July 06, 2023 | News
TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...
July 06, 2023 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly own...
July 03, 2023 | News
The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitati...
June 28, 2023 | News
Biotech start-up, Psylo, announced that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...
June 23, 2023 | News
The "Jumar Bioincubator" will be supported by cash and in-kind contributions of approximately $45 million over ten years from its founding partne...
June 22, 2023 | News
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
June 19, 2023 | News
Based on its SBDD strategy, Viva Biotech has achieved remarkable growth in its CRO drug discovery and development business through its continuous effort th...
June 16, 2023 | News
In an exclusive interview, Prem Mandalapu, General Manager, Commercial, ASEAN at Cytiva, sheds light on Cytiva's BioChallenge and its objective of supporti...
June 15, 2023 | Influencers
NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...
June 14, 2023 | News
The Company's first GalAhead™-based RNAi drug candidate, STP122G, has started a Phase I clinical trial in May 2023. The start of the trial indic...
June 14, 2023 | News
Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...
June 12, 2023 | News
Most Read
Bio Jobs
News
Editor Picks